Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 590
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02224872 | Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia | ||
| NCT03843814 | Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma | ||
| NCT00258206 | Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma | ||
| NCT07142551 | Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response | ||
| NCT02490930 | A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma | ||
| NCT00100828 | Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer | ||
| NCT00003414 | Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease | ||
| NCT01939847 | IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins | ||
| NCT06941857 | NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer | ||
| NCT05917301 | Pre-operative Hypofractionated Proton Therapy | ||
| NCT02659800 | Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas | ||
| NCT04704505 | Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) | ||
| NCT02259621 | Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC | ||
| NCT06001658 | Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers | ||
| NCT00004868 | SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy | ||
| NCT00011934 | Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia | ||
| NCT01858558 | Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma | ||
| NCT02017704 | Chemoradiation or Brachytherapy for Rectal Cancer | ||
| NCT00080626 | Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer | ||
| NCT00004464 | Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria | ||
| NCT02286921 | Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance | ||
| NCT06564623 | Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC) | ||
| NCT00278161 | Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma | ||
| NCT00010049 | Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma | ||
| NCT00265837 | Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer | ||
| NCT03035773 | Simplifying Survivorship Care Planning | ||
| NCT03800784 | Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer | ||
| NCT02225925 | Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound | ||
| NCT06205836 | Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer | ||
| NCT05823571 | Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients | ||
| NCT04843306 | Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients | ||
| NCT00363649 | Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI | ||
| NCT02993900 | Image-Guided Gynecologic Brachytherapy | ||
| NCT02146937 | A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance | ||
| NCT02115828 | A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy | ||
| NCT01784081 | Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer | ||
| NCT03291990 | 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme | ||
| NCT00867308 | Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia | ||
| NCT04517643 | TheraSphere® For Treatment of Metastases in Liver | ||
| NCT00492921 | High-Dose Cyclophosphamide for Steroid Refractory GVHD | ||
| NCT00607724 | GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT00265902 | Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's Sarcoma | ||
| NCT01417182 | Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer | ||
| NCT00426959 | Study of Image-guided Dosimetry for Interstitial Prostate Brachytherapy | ||
| NCT01752023 | A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC. | ||
| NCT03151057 | Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies | ||
| NCT04266431 | EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression | ||
| NCT01701375 | A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia | ||
| NCT06389097 | SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization | ||
| NCT03607890 | Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor |
